Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

New Film Investigates 'Fracking' For Natural Gas

June 18, 2010 4:37 pm | Podcasts | Comments

The natural gas industry says hydraulic fracturing, or "fracking," could supply the U.S. with domestic energy for almost 100 years. But environmentalists are worried it may not be safe. Josh Fox, the director of the new documentary Gasland, talks about the potential dangers of fracking.

Science Diction: How 'X-Ray' Got Its 'X'

June 18, 2010 4:37 pm | Podcasts | Comments

Dr. Howard Markel, a medical historian at the University of Michigan, discusses how the German physicist William Roentgen stumbled across the phenomenon of X-rays while playing with a cathode tube in his lab, and why Roentgen gave the electromagnetic beams the name "X-rays."

Sex lives of patients are negatively affected by rheumatoid arthritis and SLE

June 18, 2010 4:37 pm | by EurekAlert | News | Comments

(European League Against Rheumatism) Systemic Lupus Erythematosus patients from Brazil and Rheumatoid Arthritis patients from France report that their rheumatic conditions negatively affect their emotional relationships and sex lives, according to research presented today at EULAR...

TOPICS:
Advertisement

UPDATE: Congress set to restore Medicare reimbursement next week

June 18, 2010 4:36 pm | by Mass Device | News | Comments

Congress is set to restore Medicare reimbursement for physicians next week, after a 21 percent cut went into effect June 18. Congress is set to restore Medicare reimbursement rates for physicians next week, meaning a de facto 2.2 percent pay raise, after a 21 percent cut went...

TOPICS:

Delcath CEO Hobbs takes top spot on Capella's board

June 18, 2010 4:36 pm | by Mass Device | News | Comments

Eamonn Hobbs, CEO of Delcath Systems, is tapped to be Irish stent maker Capella Inc.'s chairman of the board. Eamonn Hobbs took over as board chairman for Irish stent-maker Capella Inc. Hobbs is CEO of Delcath Systems Inc. (NSDQ:DCTH), a New York-based manufacturer of...

TOPICS:

CytoPherx drums up $11.7 million for dialysis development

June 18, 2010 4:35 pm | by Mass Device | News | Comments

CytoPherx Inc. raises $11.7 million in equity, debt and options to develop a device that filters the blood of kidney-disease patients. By Brandon Glenn CytoPherx Inc. raised $11.7 million for the development of a device that filters the blood of kidney-disease patients. The Ann...

TOPICS:

Coffee May Protect Against Head and Neck Cancers

June 18, 2010 4:34 pm | by AACR | News | Comments

The embargo has been lifted on the AACR press release: “Coffee May Protect Against Head and Neck Cancers,” due to a violation by Drug Discovery and Development and the Sci-Tech Heretic blog. Reporters may post their stories effective immediately. • Caffeinated coffee protected against...

TOPICS:

Leaking Packaging, GMP Issues Result in Artegraft Warning

June 18, 2010 4:31 pm | by U.S. Food & Drug Administration | News | Comments

Recurring complaints of leaking packages of natural collagen vascular grafts have resulted in a warning letter to Artegraft that cites a number of good manufacturing (GMP) problems related to the leaks.

TOPICS:
Advertisement

FDA Acknowledges Corrections, Sends Optovue Warning Letter

June 18, 2010 4:31 pm | by U.S. Food & Drug Administration | News | Comments

Although Optovue is taking corrective action to bring a normative database used with its RTVue optical coherence tomography into compliance, it received a warning letter that notes the effectiveness of the corrections can’t be fully reviewed and evaluated because they are ongoing.

TOPICS:

Boston Scientific: Heart device helps women more

June 18, 2010 10:45 am | by The Associated Press | News | Comments

Medical device maker Boston Scientific Corp. said Friday women received a greater benefit than men from its cardiac resynchronization therapy defibrillators, according to an analysis of clinical trial data.Cardiac resynchronization therapy defibrillators shock the heart to correct irregular...

Medtronic says study shows faster catheter work

June 18, 2010 8:45 am | by The Associated Press | News | Comments

Medical device maker Medtronic Inc. said Friday late-stage study data shows two catheters it is seeking approval for in the United States work faster than a traditional approach in helping doctors treat forms of atrial fibrillation, a condition that could trigger a stroke.The Minneapolis...

Sinovac Schedules 2010 Annual Meeting of Shareholders

June 18, 2010 8:37 am | by Bio-Medicine.Org | News | Comments

BEIJING , June 18 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines in China , announced today that it will hold its 2010 Annual Meeting of Shareholders on Thursday, July 15, 2010 at 9:00 a.m. Beijing Time. The meeting will be held...

TOPICS:

Naviscan Positron Emission Mammography Technology Highlighted at the Society of Nuclear Medicine Annual Meeting

June 18, 2010 8:37 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO , June 18 /- Naviscan's Positron Emission Mammography (PEM) technology was the focus of several presentations and discussions at the Society of Nuclear Medicine Annual Meeting in Salt Lake City .  The focus represents a growing interest and validation of how PEM can play an...

TOPICS:

St. Jude Medical wins another CE Mark for cardiac ablation device

June 18, 2010 8:35 am | by Mass Device | News | Comments

St. Jude Medical Inc. won another CE Mark from the European Union for a cardiac ablation device, this time for its cryogenic Therapy Cool Flex catheter. By Brandon Glenn St. Jude Medical Inc. (NYSE:STJ) won CE Mark approval in the European Union for a cryogenic cardiac ablation...

TOPICS:

Zoll wins three-year AED contract in U.K.

June 18, 2010 8:35 am | by Mass Device | News | Comments

Zoll Medical Corp. wins a three-year contract with Britain's national heart charity, the British Heart Foundation, to be its exclusive supplier of automated external defibrillators. Zoll Medical Corp. (NSDQ:ZOLL) landed a lucrative deal as the British Heart Foundation's...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading